Policy Briefings

Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit

Warren, Scott revive bill to map foreign control of US drug supply

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head

Trump Confirms Makary Exit; Diamantas Named Acting Chief

Regeneron Closes MFN Deal; Offers Gene Therapy Free

US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact

The European Biotech Act, Explained

Multistate Lawsuit Targets CDC Childhood Vaccine Rollback

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

FDA and EMA Issue Joint AI Principles for Drug Development

EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For

TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?

J&J Strikes Drug Pricing Deal with Trump Administration

Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing

US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds

Trump Administration Launches Review of Global Drug Pricing Practises

AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal

Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks

UK Considers Raising NHS Drug Prices to Avoid US Tariffs

Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals

SK pharmteco Opens Expanded Swords Facilities for Small Molecules and HPAPIs

Andelyn Biosciences Partners With Queen’s University on AAV9-GM2 Gene Therapy

Entropy Neurodynamics Partners With BioCina on GMP Psilocin Manufacturing

Piramal Pharma Acquires 40.67% Stake in Yapan Bio for $7.95M

Genprex Selects U.S. CDMO to Scale Diabetes Gene Therapy Manufacturing

Symbiotec Pharmalab to Launch Rs 1,757 Crore($184M) IPO on August 24

Gland Pharma Appoints Deepak Sapra as New CEO

WuXi XDC Achieves GMP Release for Singapore Bioconjugate Production Line

Medipost Signs CDMO Deal with QCellS for hiPSC Cell-Culture Media

Lonza Introduces Rapid Media Service for Biopharma Development

Blue Jet Healthcare Opens New R&D Centre in Hyderabad

Eurofins CDMO Alphora Expands Kilolab and HPAPI Capabilities in Mississauga

Cabaletta Bio Selects ElevateBio as Second CDMO for Rese-cel Manufacturing

NurExone Signs Exclusive U.S. GMP Manufacturing Partnership with Made Scientific

Aurisco Pharmaceutical Becomes First Generic Oligonucleotide API Manufacturer to Pass USFDA Inspection

Xcellon Biologics Acquires 40,000-Square-Foot GMP Biologics Facility

Cycle Pharmaceuticals Selects Forma Life Sciences for CAVHANZA U.S. Manufacturing

Altasciences Expands North American Bioanalytical Network with New Laboratories

European CDMO Landscape 2025: Download the latest edition